RAPID MICRO BIOSYSTEMS, INC. - Class A common stock, $0.01 par value per share (RPID)

CUSIP: 75340L104

Q3 2025 13F Holders as of 30 Sep 2025

Holder snapshot 6 signals
Share change
-320,249
SEC-reported price per share
$3.34
Number of holders
29
Value change
-$1,092,903
Number of buys
11
Number of sells
11
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
41,037,733

Security key

75340L104

Report period

Q3 2025

Institutions

29

Top holders

10

Ownership snapshot

Top reported holders of RPID - RAPID MICRO BIOSYSTEMS, INC. - Class A common stock, $0.01 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Robert G. Spignesi Jr.
Disclosed value leader
Bain Capital Life Science...
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G 13F Lead comparable stake: 6.3% 13D/G row: Robert G. Spignesi Jr. Showing 1-6 of 15 holder rows.

Quick read

Robert G. Spignesi Jr. leads the comparable SEC ownership view at 6.3%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Robert G. Spignesi Jr.'s linked filing trail.
Comparable ownership Top 5
Robert G. Spignesi Jr. 6.3%
Bain Capital Life Sciences Invest... 21%
ABG-WTT Global Life Science Capit... 4.5%
Schonfeld Strategic Advisors LLC 2.5%
Parkman Healthcare Partners LLC 2.2%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Robert G. Spignesi Jr.
13D/G
SPIGNESI ROBERT G JR
6.3%
$9,133,033
2,647,256 shares
$0 28 Mar 2024
Bain Capital Life Sciences Investors, LLC
13F
Company
13F
21%
$29,099,232
8,434,560 shares
30 Jun 2025
ABG-WTT Global Life Science Capital Partners GP Ltd
13F
Company
13F
4.5%
$6,376,621
1,848,296 shares
30 Jun 2025
Schonfeld Strategic Advisors LLC
13F
Company
13F
2.5%
$3,579,953
1,037,668 shares
30 Jun 2025
Parkman Healthcare Partners LLC
13F
Company
13F
2.2%
$3,151,378
913,443 shares
30 Jun 2025
VANGUARD GROUP INC
13F
Company
13F
2.2%
$3,120,053
904,363 shares
30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
29
Shares
14,828,987
Rows available
29
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
29
Q3 2025 holders
29
Holder diff
0
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .